Wyeth merger costs weigh on Pfizer
May 04, 2010 at 09:12 AM EDT
BOSTON (MarketWatch) - Pfizer Inc. reported markedly lower first-quarter earnings early Tuesday, due largely to hefty costs associated with its 2009 mega-merger with rival Wyeth.
